XCUR - VXRT SAVA And GALT among pre-market gainers
Ever-Glory EVK +75% announces $5 million share buyback plan Exicure (NASDAQ:XCUR) +36% and Ipsen enter into exclusive collaboration targeting rare neurodegenerative disorders AgriFORCE (AGRI) +20%. Autolus Therapeutics (NASDAQ:AUTL) +18%. and Moderna sign Option and License Agreement for access to proprietary targeting technology from Autolus Lava Therapeutics B.V. (NASDAQ:LVTX) +19%. BSQUARE (NASDAQ:BSQR) +17%. Infinity Pharmaceuticals INFI +16% adds another bull at JPMorgan on potential of cancer therapy Atlas Technical (NASDAQ:ATCX) +16%. Vaxart (NASDAQ:VXRT) +12%. Dolphin Entertainment (NASDAQ:DLPN) +13% six pro football legends line up for unprecedented NFT drop VYNE Therapeutics (NASDAQ:VYNE) +9% announces approval of AMZEEQ® (Minocycline) and ZILXI® (Minocycline) in Chinese economic pilot zone NanoVibronix (NASDAQ:NAOV) +10%. Galmed Pharmaceuticals GLMD +8% on FDA green light to use Aramchol Meglumine in late-stage ARMOR study Cassava Sciences (NASDAQ:SAVA) +8%. Affirm Holdings AFRM +8% as Afterpay deal may raise profile as takeover target ON Semiconductor ON +8% on Q2 earnings Eton Pharmaceuticals (NASDAQ:ETON) +7%. Ra Medical Systems (NYSE:RMED) +6%. Galectin Therapeutics (NASDAQ:GALT) +6%. Creatd (NASDAQ:CRTD) +6% announces memorandum of
For further details see:
VXRT, SAVA And GALT among pre-market gainers